In prostate adenocarcinoma, this non-canonical function of EZH2 can collaborate with the AR transcriptional machinery to drive AR-signaling (19–21) or with N-myc to modulate plasticity (22, 23). This evidence concerns the gene AR and prostate adenocarcinoma.